Ventricular septal defect complicating myocardial infarction: A case of delayed percutaneous transcatheter closure

Qianhang Xia1, Meihong Chen1, Qingxian Tu2

  • 1Zunyi Medical University, Zunyi, China.

Insights

Delayed percutaneous transcatheter closure is a viable option for myocardial defects in patients without severe organ dysfunction. This approach offers a potential treatment pathway for individuals experiencing delayed medical intervention.

Area of Science:

  • Cardiology
  • Interventional Cardiology

Background:

  • The COVID-19 pandemic led to delayed medical care for cardiovascular conditions due to patient-related fears.
  • Myocardial defects, such as apical myocardial defects, can arise from conditions like myocardial infarction.

Observation:

  • A 57-year-old man presented with chest pain during the pandemic, delaying treatment for 4 months.
  • Initial diagnosis revealed an old myocardial infarction and an apical myocardial defect.
  • The patient initially refused surgical or percutaneous interventions, opting for observation.

Findings:

  • Symptoms of chest tightness and shortness of breath aggravated after 22 months of observation.
  • Percutaneous transcatheter closure was successfully performed, leading to patient recovery.
  • The case highlights the effectiveness of delayed intervention in specific patient profiles.

Implications:

  • Delayed percutaneous transcatheter closure can be a safe and effective treatment for apical myocardial defects.
  • This approach is suitable for patients without severe organ dysfunction or hemodynamic instability.
  • The study underscores the importance of considering delayed interventions in managing cardiovascular conditions, even post-pandemic.